APOE ε4 carriership also demonstrates a stronger association with tau signal on positron emission tomography (PET) and in the cerebrospinal fluid of women compared to men, compounding this disparity in tau accumulation and rates of AD.41, 42, 43, 44. This evidence concerns the gene MAPT and Alzheimer disease.